Cost-Effectiveness of Biphasic Insulin Aspart 50 Versus Biphasic Human Insulin 50 in People with Type 2 Diabetes Mellitus in China
Nov 1, 2016, 00:00
10.1016/j.jval.2016.08.211
https://www.valueinhealthjournal.com/article/S1098-3015(16)30791-4/fulltext
Title :
Cost-Effectiveness of Biphasic Insulin Aspart 50 Versus Biphasic Human Insulin 50 in People with Type 2 Diabetes Mellitus in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30791-4&doi=10.1016/j.jval.2016.08.211
First page :
A897
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2785